Others

CIPLA LTD. - Revised Disclosure On USFDA Cgmp Inspection Completed At Ciplas API Manufacturing Facility In Virgonagar, Bengaluru

| Updated on July 20, 2019 Published on July 20, 2019

This is further to our letter dated 19th July 2019.The dates of inspection were inadvertently mentioned as 15th June 2019 to 19th June 2019 instead of 15th July 2019 to 19th July 2019. Please read the revised intimation as under:

"Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the United States Food and Drug Administration (USFDA) conducted a routine cGMP inspection at our API manufacturing facility in Virgonangar,Bengaluru, from 15th July, 2019 to 19th July, 2019.

The inspection ended with 7 observations, none of which were repeat or related to data integrity. The Company will respond to the agency within the stipulated timeline."

Kindly take the above information on record.

Pdf Link: CIPLA LTD. - Revised Disclosure On USFDA Cgmp Inspection Completed At Ciplas API Manufacturing Facility In Virgonagar, Bengaluru

Source : BSE - www.bseindia.com

Published on July 20, 2019
This article is closed for comments.
Please Email the Editor